Antibiotic resistance islands in A320 (RUH134), the reference strain for Acinetobacter baumannii global clone 2
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibiotic resistance islands in A320 (RUH134), the reference strain for Acinetobacter baumannii global clone 2
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 67, Issue 2, Pages 335-338
Publisher
Oxford University Press (OUP)
Online
2011-10-22
DOI
10.1093/jac/dkr447
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diversity and Evolution of AbaR Genomic Resistance Islands in Acinetobacter baumannii Strains of European Clone I
- (2011) Lenka Krizova et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Aminoglycoside resistance in multiply antibiotic-resistant Acinetobacter baumannii belonging to global clone 2 from Australian hospitals
- (2011) S. J. Nigro et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- AbaR4 replaces AbaR3 in a carbapenem-resistant Acinetobacter baumannii isolate belonging to global clone 1 from an Australian hospital
- (2011) M. Hamidian et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- GIsul2, a genomic island carrying the sul2 sulphonamide resistance gene and the small mobile element CR2 found in the Enterobacter cloacae subspecies cloacae type strain ATCC 13047 from 1890, Shigella flexneri ATCC 700930 from 1954 and Acinetobacter baumannii ATCC 17978 from 1951
- (2011) S. J. Nigro et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The multiresistant Acinetobacter baumannii European clone I type strain RUH875 (A297) carries a genomic antibiotic resistance island AbaR21, plasmid pRAY and a cluster containing ISAba1-sul2-CR2-strB-strA
- (2011) S. J. Nigro et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Use of the Accessory Genome for Characterization and Typing of Acinetobacter baumannii
- (2011) J. F. Turton et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Genomewide Analysis of Divergence of Antibiotic Resistance Determinants in Closely Related Isolates of Acinetobacter baumannii
- (2010) M. D. Adams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A 63 kb genomic resistance island found in a multidrug-resistant Acinetobacter baumannii isolate of European clone I from 1977
- (2010) Lenka Krizova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of Epidemiologically Unrelated Acinetobacter baumannii Isolates from Four Continents by Use of Multilocus Sequence Typing, Pulsed-Field Gel Electrophoresis, and Sequence-Based Typing of blaOXA-51-like Genes
- (2010) A. Hamouda et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool
- (2010) Laure Diancourt et al. PLoS One
- AbaR5, a Large Multiple-Antibiotic Resistance Region Found in Acinetobacter baumannii
- (2009) V. Post et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Global spread of carbapenem-resistant Acinetobacter baumannii
- (2009) P. G. Higgins et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Whole-Genome Pyrosequencing of an Epidemic Multidrug-Resistant Acinetobacter baumannii Strain Belonging to the European Clone II Group
- (2008) M. Iacono et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ATPase genes of diverse multidrug-resistant Acinetobacter baumannii isolates frequently harbour integrated DNA
- (2008) F. Shaikh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II
- (2008) A. Nemec et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii
- (2008) M. D. Adams et al. JOURNAL OF BACTERIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started